Working Hours

Mon - Sat 9:00 - 6:00
LORTINIL TZ 1.125GM
LORTINIL TZ 1.125GM
LORTINIL TZ 1.125GM
LORTINIL TZ 1.125GM
LORTINIL TZ 1.125GM
LORTINIL TZ 1.125GM

LORTINIL TZ 1.125GM

Price 88.0 INR/ Piece

MOQ : 50 Pieces

LORTINIL TZ 1.125GM Specification

  • Drug Type
  • Injection
  • Ingredients
  • LORTINIL TZ Injection Ceftazidime & Tazobactam Brand Name: LORTINIL TZ Composition: Ceftazidime & Tazobactam Injection Manufacturer/Marketer: Aurobindo Pharma Ltd Veritaz Division Dosage Form: Dry Powder for Injection Packaging Type: Vial Route of Administration: Intravenous (IV) / Intramuscular (IM) Prescription Required: Yes Product Description: LORTINIL TZ Injection is a broad-spectrum antibiotic combination containing Ceftazidime and Tazobactam. Ceftazidime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that enhances the effectiveness of Ceftazidime against resistant bacterial strains. It is widely used in hospitals and clinical settings for the treatment of moderate to severe bacterial infections. Indications: Respiratory tract infections Urinary tract infections Intra-abdominal infections Skin and soft tissue infections Bone and joint infections Septicemia Key Features: Broad-spectrum antibacterial coverage Effective against beta-lactamase producing organisms Suitable for critical care and hospital use Manufactured by a reputed pharmaceutical company Storage: Store in a cool, dry place below 25 C. Protect from light and moisture. Note: To be administered under the supervision of a qualified healthcare professional only.
  • Physical Form
  • Liquid
  • Recommended For
  • Doctor
  • Dosage Guidelines
  • As per Instructions
  • Quantity
  • 50 Pieces
  • Storage Instructions
  • Cool & Dry Place
 

LORTINIL TZ 1.125GM Trade Information

  • Minimum Order Quantity
  • 50 Pieces
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Pieces Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

About LORTINIL TZ 1.125GM

LORTINIL TZ Injection Ceftazidime & Tazobactam

Brand Name: LORTINIL TZ
Composition: Ceftazidime & Tazobactam Injection
Manufacturer/Marketer: Aurobindo Pharma Ltd Veritaz Division
Dosage Form: Dry Powder for Injection
Packaging Type: Vial
Route of Administration: Intravenous (IV) / Intramuscular (IM)
Prescription Required: Yes

Product Description:

LORTINIL TZ Injection is a broad-spectrum antibiotic combination containing Ceftazidime and Tazobactam. Ceftazidime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that enhances the effectiveness of Ceftazidime against resistant bacterial strains.

It is widely used in hospitals and clinical settings for the treatment of moderate to severe bacterial infections.

Indications:

         Respiratory tract infections

         Urinary tract infections

         Intra-abdominal infections

         Skin and soft tissue infections

         Bone and joint infections

         Septicemia

Key Features:

         Broad-spectrum antibacterial coverage

         Effective against beta-lactamase producing organisms

         Suitable for critical care and hospital use

         Manufactured by a reputed pharmaceutical company

Storage:

Store in a cool, dry place below 25C. Protect from light and moisture.

Note: To be administered under the supervision of a qualified healthcare professional only.


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anaesthetics Injection Category

LINTAZ 4.5GM

LINTAZ 4.5GM

Price 95.0 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 50 Pieces

Ingredients : Brand Name: LINTAZ 4.5 G Generic Name / Content: Piperacillin + Tazobactam Injection I.P. 4.5 g Company: Aurobindo Pharma Ltd LINTAZ 4.5 G Injection is a broadspectrum injectable antibiotic combining Piperacillin (a penicillinclass antibiotic) and Tazobactam (a betalactamase inhibitor). This dualaction formulation provides enhanced efficacy against betalactamase producing bacteria, covering a wide range of Grampositive and Gramnegative infections. Piperacillin disrupts bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation, ensuring stronger antibacterial activity. The sterile injectable form is intended for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Intraabdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Broadspectrum penicillin with betalactamase inhibitor Effective against resistant bacterial strains Rapid and reliable antibacterial action Sterile injectable formulation suitable for hospital use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 4.5 g per vial Content: Piperacillin + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Physical Form : Liquid

Drug Type : Injection

Cisatracurium Besylate Injection USP

Cisatracurium Besylate Injection USP

Price 319 INR / Vial

Minimum Order Quantity : 100 Vials

Quantity : 1 Pieces

Physical Form : Liquid

Drug Type : Injection

ROPIN 0.20% 50ML

ROPIN 0.20% 50ML

Price 306.5 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 50 Unit

Ingredients : ROPIN 0.20% 50ML Ropivacaine Hydrochloride Injection I.P. Brand: ROPIN Injection Content: Ropivacaine Hydrochloride I.P. 0.2% w/v (2 mg / ml) Company / Manufacturer: Neon Laboratories Ltd Pack: 50 ml Vial Category: Local Anesthetic / AmideType Regional AnestheticProduct Description ROPIN 0.20% 50ml Vial contains Ropivacaine Hydrochloride, a longacting amidetype local anesthetic solution formulated for parenteral administration. The 0.2% concentration is specifically designed to provide effective sensory nerve blockade while minimizing motor block, making it ideal for continuous pain relief. It is widely used in postoperative wards, intensive care units, and delivery rooms to provide stable, longlasting regional pain control during surgical recovery or childbirth with enhanced systemic safety margins.Key Uses Production of continuous epidural infusion analgesia for labor pain management during childbirth Postoperative pain management following major orthopedic, abdominal, or thoracic surgeries Continuous peripheral nerve blocks and infiltration anesthesia for local pain control Longterm acute pain management in intensive care settings How It Works Ropivacaine works by blocking the generation and conduction of nerve impulses. It diffuses into the nerve sheath and binds selectively to the intracellular sodium channels of nerve fibers. This action prevents the influx of sodium ions through the cell membrane, stopping the electrical depolarization of the nerve cell. By blocking these pathways, the drug temporarily prevents pain signals from traveling from the affected site up the spinal cord to the brain.Directions for Use Administer via epidural infusion, peripheral nerve block, or local tissue infiltration routes Visually check the solution inside the vial for any particles, leaks, or cloudiness before extraction Extract using clean, sterile syringes directly through the rubber stopper core Must be calculated, handled, and administered exclusively by a registered anesthesiologist or clinician Key Features Optimized concentration that provides reliable pain relief with minimal loss of skeletal muscle control Extended therapeutic window that delivers prolonged postsurgical and labor analgesia High volume 50 ml vial format designed to support continuous infusion pumps or repeated dosing protocols Fabricated under international sterile manufacturing standards by Neon Laboratories Ltd Possible Side Effects Hypotension or sudden temporary drop in systemic blood pressure Nausea, vomiting, or mild dizziness Important Safety Notes Storage Temperature: Store below 30 C in a cool, dry place. Protect from direct light lines and do not freeze. For local and regional blocks only; strictly contraindicated for intravenous regional anesthesia methods Avoid application directly into highly inflamed or infected tissue surfaces Schedule H Prescription Drug: Restricted for institutional supply to verified buyers with drug wholesale licenses

Physical Form : Liquid

Drug Type : Injection

LIN + VE TAB 600MG

LIN + VE TAB 600MG

Price 354.0 INR / Box

Minimum Order Quantity : 50 Boxes

Quantity : 50 Boxes

Ingredients : Brand Name: LIN+IV 600 mg Tablet Generic Name / Content: Linezolid Tablet I.P. 600 mg Company: Aurobindo Pharma Ltd LIN+IV 600 mg Tablet contains Linezolid, a synthetic oxazolidinoneclass antibiotic used for the treatment of serious Grampositive bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and multiplication of susceptible bacteria. This oral formulation is suitable for patients requiring outpatient therapy or for hospital use when intravenous therapy is not needed. Indications Complicated skin and soft tissue infections Communityacquired pneumonia (CAP) Hospitalacquired pneumonia (HAP) Infections caused by methicillinresistant Staphylococcus aureus (MRSA) Vancomycinresistant Enterococcus faecium (VRE) infections Key Features Oxazolidinoneclass broadspectrum antibiotic Effective against multidrugresistant Grampositive bacteria Oral tablet formulation for easy administration Rapid onset of action Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Tablet Category: Oral Antibiotic (Oxazolidinone Class) Strength: 600 mg Content: Linezolid I.P. Packaging & Storage Supplied in blister packs or bottles as per packaging Store in a cool, dry place below 25 C Protect from light and moisture Use under qualified medical supervision



Back to top